These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35369306)

  • 21. Improved patient selection for cardiac resynchronization therapy by normalization of QRS duration to left ventricular dimension.
    Zweerink A; Wu L; de Roest GJ; Nijveldt R; de Cock CC; van Rossum AC; Allaart CP
    Europace; 2017 Sep; 19(9):1508-1513. PubMed ID: 27707784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
    Linde C; Abraham WT; Gold MR; St John Sutton M; Ghio S; Daubert C;
    J Am Coll Cardiol; 2008 Dec; 52(23):1834-1843. PubMed ID: 19038680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
    Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
    Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. His bundle pacing for cardiac resynchronization therapy: a systematic literature review and meta-analysis.
    Qi J; Jia X; Wang Z
    J Interv Card Electrophysiol; 2020 Nov; 59(2):463-470. PubMed ID: 32748157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits of left ventricular endocardial pacing comparing failed implants and prior non-responders to conventional cardiac resynchronization therapy: A subanalysis from the ALSYNC study.
    Biffi M; Defaye P; Jaïs P; Ruffa F; Leclercq C; Gras D; Yang Z; Gerritse B; Ziacchi M; Morgan JM;
    Int J Cardiol; 2018 May; 259():88-93. PubMed ID: 29579617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute echocardiographic optimization of multiple stimulation configurations of cardiac resynchronization therapy through quadripolar left ventricular pacing: a tailored approach.
    Calò L; Martino A; de Ruvo E; Minati M; Fratini S; Rebecchi M; Lanzillo C; Fagagnini A; Borrelli A; De Luca L; Sciarra L
    Am Heart J; 2014 Apr; 167(4):546-54. PubMed ID: 24655704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    Kanai M; Yagishita D; Shoda M; Ejima K; Hagiwara N
    J Cardiol; 2022 Jan; 79(1):6-14. PubMed ID: 34426046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?
    Tawfik Ghanem M; Allam LE; Samir Ahmed R
    Indian Heart J; 2019; 71(3):229-234. PubMed ID: 31543195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of image-guided techniques in cardiac resynchronization therapy: a meta-analysis.
    Hu X; Xu H; Hassea SRA; Qian Z; Wang Y; Zhang X; Hou X; Zou J
    BMC Cardiovasc Disord; 2021 May; 21(1):255. PubMed ID: 34024286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of pacing site on QRS duration and its relationship to hemodynamic response in cardiac resynchronization therapy for congestive heart failure.
    Derval N; Bordachar P; Lim HS; Sacher F; Ploux S; Laborderie J; Steendijk P; Deplagne A; Ritter P; Garrigue S; Denis A; Hocini M; Haissaguerre M; Clementy J; Jaïs P
    J Cardiovasc Electrophysiol; 2014 Sep; 25(9):1012-1020. PubMed ID: 24891271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Right ventricular lead location and outcomes among patients with cardiac resynchronization therapy: A meta-analysis.
    Ali-Ahmed F; Dalgaard F; Allen Lapointe NM; Kosinski AS; Blumer V; Morin DP; Sanders GD; Al-Khatib SM
    Prog Cardiovasc Dis; 2021; 66():53-60. PubMed ID: 33864874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cardiac resynchronization therapy on patients with heart failure and narrow QRS complexes: a meta-analysis of five randomized controlled trials.
    Wang G; Zhao Z; Zhao S; Ding S; Shen S; Wang L
    J Interv Card Electrophysiol; 2015 Oct; 44(1):71-9. PubMed ID: 26162538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
    Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
    Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility and efficacy of left bundle branch area pacing in patients indicated for cardiac resynchronization therapy.
    Li Y; Yan L; Dai Y; Zhou Y; Sun Q; Chen R; Lin J; Jin Y; Chen F; Guo X; Chen K; Zhang S
    Europace; 2020 Dec; 22(Suppl_2):ii54-ii60. PubMed ID: 33370801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left bundle branch pacing in heart failure patients with left bundle branch block: A systematic review and meta-analysis.
    Cheng Y; Wang Z; Li Y; Qi J; Liu J
    Pacing Clin Electrophysiol; 2022 Feb; 45(2):212-218. PubMed ID: 34766359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac resynchronization therapy by left bundle branch area pacing in patients with heart failure and left bundle branch block.
    Zhang W; Huang J; Qi Y; Wang F; Guo L; Shi X; Wu W; Zhou X; Li R
    Heart Rhythm; 2019 Dec; 16(12):1783-1790. PubMed ID: 31513945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.